An interventional study of rice formula and placebo in Cow Milk Allergy, sponsored by United Pharmaceuticals. Completed at 4 sites in 3 countries. Open to participants aged 1 Month to 36 Months. Per ClinicalTrials.gov, last updated 2020-11-04.
Sponsored by United Pharmaceuticals · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies in Milk Hypersensitivity with a site in France — 1 open to participants now, 1 under way, none of them phase 3. Milk Hypersensitivity · France.
Among the 12 studies in Milk Hypersensitivity with a site in France, this one is the 5th largest by enrollment of the 10 interventional ones that give a count, is the only one that started in 2018, is one of 8 with no phase, and was the 10th registered.
147 studies on the registry are indexed under Milk Hypersensitivity; 26 are open to participants now.
Browse Milk Hypersensitivity studies →1 of the 12 studies in Milk Hypersensitivity with a site in France is open now. Recruiting first, the newest first:
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement · Sites in France
Ages 18–65 · Healthy volunteers
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 16 Milk Hypersensitivity studies recruiting now, 1 (6%) sets no upper age limit and 15 (94%) stop at 75 or younger; 15 take children under 18; 1 takes healthy volunteers.
This study: 1 Month to 36 Months · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 1 started in 2018.
This study's enrollment of 72 is close to the median of 68 across 95 interventional studies indexed under Milk Hypersensitivity.
Median enrollment 62 across the 10 interventional studies, 64 across the 2 observational. Of the 10 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
8 of 12 have an industry lead sponsor. The 10 most frequent:
United Pharmaceuticals is the lead sponsor of 13 studies on the registry; 2 are open to participants now.
United Pharmaceuticals has 6 studies filed under Milk Hypersensitivity — fewer than ten, so there is no comparison to draw.
1 of the studies in Milk Hypersensitivity with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07239856Institut National de Recherche pour l'Agriculture, l'Alimentation et l'EnvironnementGoat vs. Cow Milk Digestive Tolerance | 2027-02 |
Add it to your calendar (.ics) → With an account.
Among the 12 studies in Milk Hypersensitivity with a site in France, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The aim of this study is to show the hypoallergenicity of a new thickened rice based formula (TRHF) through a double blind placebo controlled food challenge (DBPCFC), as recommended by the American Academy of Pediatrics, in subjects with IgE-mediated CMA and in subjects with non-IgE-mediated CMA.
The study is made of 2 different steps : 1st step is a double blind randomised food challenge where the new formula is compared to a placebo.
The second part of the trial consists in an open phase during which all infants will be fed with the study formula.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Each subjects will receive both TRHF and placebo formula during the 1st part of the study
Dietary Supplement: rice formula · Dietary Supplement: placebo
Each subjects will receive both TRHF and placebo formula during the 1st part of the study
Dietary Supplement: rice formula · Dietary Supplement: placebo
new rice based thickened formula
formula previously tolerated by the subject - only for the 1st part of the study
hypoallergenicity
the percentage of children tolerating the formula during the double blind placebo controlled food challenge (TRHF 2017 vs. placebo formula).
Time frame: 7 days
Regurgitations
assessed through Vandenplas score ranging from 0 (=less than 2 regurgitation episodes / day) to 6 (=Regurgitation of the complete volume after each feeding)
Time frame: 1, 2, 3, 4, 5 and 6 months
Vomiting
(on a 4 level scale)
Time frame: 1, 2, 3, 4, 5 and 6 months
Abdominal pain
(severity on a 4 level scale)
Time frame: 1, 2, 3, 4, 5 and 6 months
Bloating and gas
(severity on a 4 level scale)
Time frame: 1, 2, 3, 4, 5 and 6 months
Stool consistency
assessed through Bristol Stools Form Scale from Type A ( Separate hard lumps, like nuts (hard to pass)) to Type G (Watery, not solid pieces - entirely liquid )
Time frame: 1, 2, 3, 4, 5 and 6 months
Stool frequency
(number of stool per day or per week)
Time frame: 1, 2, 3, 4, 5 and 6 months
Blood in stools
(presence/absence)
Time frame: 1, 2, 3, 4, 5 and 6 months
Sleeping time over 24h satisfaction
(presence/absence)
Time frame: 1, 2, 3, 4, 5 and 6 months
Unexplained crying
(yes/no)
Time frame: 1, 2, 3, 4, 5 and 6 months
Respiratory symptoms
(severity on a 4 level scale)
Time frame: 1, 2, 3, 4, 5 and 6 months
Urticaria
(presence/absence)
Time frame: 1, 2, 3, 4, 5 and 6 months
Angioedema
(presence/absence)
Time frame: 1, 2, 3, 4, 5 and 6 months
Eczema
severity assessed through SCORAD
Time frame: 1, 2, 3, 4, 5 and 6 months
Weight
expressed in kg and in z scores according to the World Health Organization (WHO) Child Growth Standards
Time frame: 1, 2, 3, 4, 5 and 6 months
Height
expressed in cm and in z scores according to the WHO Child Growth Standards
Time frame: 1, 2, 3, 4, 5 and 6 months
BMI
expressed in value and z scores according to the WHO Child Growth Standards
Time frame: 1, 2, 3, 4, 5 and 6 months
Head circumference
expressed in cm and in z scores according to the WHO Child Growth Standards
Time frame: 1, 2, 3, 4, 5 and 6 months
Number of patients with treatment emergent Adverse Events
Time frame: 1, 2, 3, 4, 5 and 6 months
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Aug 2018 to primary completion in Sep 2020, 24 months.
Of 34 interventional studies with no phase under Milk Hypersensitivity, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 48. This study's 24 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
United Pharmaceuticals